Irrus Investments' Portfolio

Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options.

Developing tools to ensure everyone has bespoke access to gaming and the digital world.

Cinclus Pharma is a Swedish clinical-stage pharma company developing small molecules for the treatment of gastric acid-related diseases. Our lead candidate linaprazan glurate is being developed for the treatment of moderate to severe gastroesophageal reflux disease (GERD).

OncoAssure is a medical diagnostics company that identifies, develops, and commercialises clinically important biomarkers to significantly improve cancer management and treatment.

Developing an innovative drainage technology to treat malignant pleural effusions (MPE)

AllView’s technology enables patients, hospitals and clinics to receive rapid, accurate diagnosis from leading Mohs1 surgeons, consultant dermatologists and plastic surgeons. It provides Ireland’s fastest route to access a Consultant Dermatologist diagnosis.

Remote patient monitoring (RPM) for patients at risk of diabetic foot disease. Thermal and visual assessment in a single scan. Award winning, patented design.

Ovagen is a biotechnology company that has developed a proprietary process of producing Germ Free chicken eggs and Germ Free birds in commercial quantities for use primarily in the vaccine and pharmaceutical industry.

Sigrid Therapeutics is a clinical-stage biotechnology company pioneering a new class of therapies to prevent and treat lifestyle diseases.

Gasgon Medical is an award winning start-up medical device company, based in Cork, Ireland, developing innovative fluid management products for the clinical market, including AirVault™, a single-use device to remove air bubbles from IV fluids.

Sigyn Therapy is a patent-pending blood purification technology to mitigate Cytokine Storm Syndrome through the broad-spectrum depletion of life-threatening inflammatory targets from the entire bloodstream.

ArunA Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders.

AniV8 (pronounced An-i-vate) is a company designed to become the leading developer of clinical sensor technology recommended by veterinarians to diagnose and monitor common animal disease states.

Sedana medical, a Swedish company, are the developers of the AnaConDa (Anaesthetic Conserving Device) which is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as Isoflurane or Sevoflurane to invasively ventilated patients.

Developer of medical devices designed to improve the outcome of cancer treatment. The company's technology has a unique IP that facilitates for painless delivery of electroporation energy endoscopically which greatly facilitates cancer treatment, enabling physicians to target tumors located anywhere on the body.

CroíValve has developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation.